Beam Looks Beyond Liver With Guide Therapeutics Acquisition

Company Pays $120m Upfront

 
• By Alaric DeArment
  
Genetic engineering and gene manipulation concept. Hand is replacing part of a DNA molecule. 3D rendered illustration of DNA.
Beam Therapeutics acquires Guide Therapeutics for $120m upfront and up to $320m in milestones. • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from R&D

More from Scrip